Source: Montreal Gazette
Date: October 5, 2007
Summary:
Researchers from Quebec and Harvard University are working on a promising vaccine to treat people suffering from Lou Gehrig's disease, a neuro-muscular disorder, that would target a toxic protein in people with the genetic mutation.
